| pubmed-article:12571210 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12571210 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12571210 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:12571210 | lifeskim:mentions | umls-concept:C0001962 | lld:lifeskim |
| pubmed-article:12571210 | lifeskim:mentions | umls-concept:C0154141 | lld:lifeskim |
| pubmed-article:12571210 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:12571210 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12571210 | pubmed:dateCreated | 2003-2-6 | lld:pubmed |
| pubmed-article:12571210 | pubmed:abstractText | Therapeutic options for toxic thyroid nodules (TTNs) are surgery, radioiodine (RAI), and percutaneous ethanol injection (PEI). Surgery is generally considered for TTNs larger than 4 cm. However, some patients may be at high surgical risk. The purpose of the study was to evaluate the efficacy of 2 nonsurgical modalities for these TTNs. | lld:pubmed |
| pubmed-article:12571210 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12571210 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12571210 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12571210 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12571210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12571210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12571210 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12571210 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12571210 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:12571210 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:12571210 | pubmed:author | pubmed-author:TrischittaVin... | lld:pubmed |
| pubmed-article:12571210 | pubmed:author | pubmed-author:ModoniSergioS | lld:pubmed |
| pubmed-article:12571210 | pubmed:author | pubmed-author:FruscianteVin... | lld:pubmed |
| pubmed-article:12571210 | pubmed:author | pubmed-author:ZingrilloMatt... | lld:pubmed |
| pubmed-article:12571210 | pubmed:author | pubmed-author:ConteMatteoM | lld:pubmed |
| pubmed-article:12571210 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12571210 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:12571210 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12571210 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12571210 | pubmed:pagination | 207-10 | lld:pubmed |
| pubmed-article:12571210 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:meshHeading | pubmed-meshheading:12571210... | lld:pubmed |
| pubmed-article:12571210 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12571210 | pubmed:articleTitle | Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules. | lld:pubmed |
| pubmed-article:12571210 | pubmed:affiliation | Unità di Endocrinologia, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. m.zingrillo@tin.it | lld:pubmed |
| pubmed-article:12571210 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12571210 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12571210 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12571210 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12571210 | lld:pubmed |
